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015 Risk of Amputation following Limb Salvage Surgery 
with Endoprosthetic Replacement
Lee M Jeys, Robert J Grimer, Simon R Carter, Roger M Tillman
Royal Orthopaedic Hospital Oncology Service, Royal Orthopaedic 
Hospital
Objective: Endoprosthetic Replacements (EPRs) are one of the
most  commonly  used  types  of  limb  salvage  following  surgical
excision  of  bone  tumours.  The  advantage  of  Endoprosthetic
Replacements are their initial reliability and the rapid restoration
of function along with their ready availability. The problems with
Endoprosthetic Replacements are the long term problems of wear,
loosening,  infection  and  mechanical  failure.  Increasing  and
insolvable problems may lead to the necessity for amputation. This
paper  assesses  the  risk  of  amputation following  Endoprosthetic
Replacement.
Methods: Information  was  collected  from  a  prospectively
recorded database in the unit. Information was used to identify the
patients having undergone EPRs and those with subsequent ampu-
tations.
Results: A total of 1262 patients have undergone Endoprosthetic
Replacement surgery at our centre in the past 34 years. They have
a total of 6507 patient years of follow up. A total of 112 patients
have had subsequent amputation (8.9%). The reasons for ampu-
tation were local recurrence in 71(64.4%), infection in 38(33.9%),
mechanical failure in 2(1.8%) and continued pain in 1 case(0.8%).
The risk of amputation was greatest in the proximal tibia 15.5%
(n=38/246),  followed  by  pelvis  10.2%(5/49),  and  femur  7.4%
(n=58/784), whilst the risk of amputation was least in the humerus
at 6.4% (n=11/182). The time to amputation varied from 2 days
to 16.37 years, with a mean of 31 months. The risk of amputation
decreased with time although 10% of the amputations took place
more than 5 years after implantation.
Conclusion: The greatest risk of amputation is in the first 5 years
and is due to local recurrence, whilst infection poses the next great-
est threat. The risk decreases with time. Attempts to control both
local recurrence and infection will decrease the need for amputa-
tion. Late failure of the EPRs, even in young patients does not
seem to be a major cause of amputation thus far.
017 Reconstruction following Total Scapular Resection: 
Analysis of Humeral Suspension Versus Endoprosthetic 
Reconstruction
Jacob Bickels1, James C Wittig2, Yehuda Kollender1, Kristen 
L. Kellar-Graney2, Isaac Meller1, Martin Miles Malawer2
1National Unit of Orthopedic Oncology Tel-Aviv Sourasky Medical 
Center, 2Division of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center
Objective: Total scapular resection causes a significant functional
loss because of the sacrifice of the glenoid, which serves as a stable
base for shoulder motion. The authors analyze their experience
with two types of reconstructions following total scapular resec-
tion; suspension of the  humeral head from the  clavicle  without
endoprosthetic reconstruction of the scapula and endoprosthetic
scapular reconstruction.
Methods: Between  1979  and  1997,  the  authors  treated  23
patients with scapular tumors that required total scapular resec-
tion.  Patients  were  diagnosed  with  14  bone  and  9  soft–tissue
tumors. Resection included total scapulectomy in 12 patients and
enbloc resection of the scapula and humeral head in 11 patients.
Reconstruction:  All  eleven  patients  who  had  resection  of  their
humeral  head  underwent  reconstruction  of  the  humerus  with
endoprosthesis. Scapular endoprosthesis was further installed in 7
patients and suspension of the humeral head from the clavicle with
a Dacron tape was performed in 16 patients (Suspension of the
prosthetic humeral head from the clavicle – 4 patients; suspension
of the native humeral head from the clavicle – 12 patients). Endo-
prosthetic reconstruction of the scapula was feasible only when the
periscapular musculature was sufficient for endoprosthetic attach-
ment and coverage. The scapular prosthesis was attached to the
prosthetic humeral head with a Goretex® sleeve, which served as
an artificial joint capsule. All patients were followed for a minimum
of 2 years; follow-up included physical examination, radiological
evaluation and functional evaluation according to the American
Musculoskeletal Tumor Society system.
Results: Elbow range-of-motion and hand dexterity were similar
in the two groups of patients. However, compared with patients
who had undergone humeral suspension, those who had scapular
endoprosthesis had better abduction (60°-90° vs. 10°-20°) of the
shoulder  joint.  Moreover,  these  patients  had  better  cosmetic
appearance of the  shoulder girdle. There were no deep  wound
infections, prosthetic failures, or secondary amputations. Overall,
6 patients who had scapular prosthesis (86%) and 10 patients who
had humeral suspension (62%) had a good-to-excellent functional
outcome.
Conclusion: The number of patients who underwent a scapular
endoprosthetic reconstruction is small and does not allow a valid
statistical analysis; however, the authors feel that scapular endo-
prosthesis reconstruction is associated with better functional and
cosmetic outcomes, when compared to humeral suspension. The
authors recommend reconstruction of the scapula with endopros-
thesis  when  periscapular  musculature,  remaining  after  tumor
resection allows attachment and coverage of the prosthesis.
018 Extensile Exposure of the Axilla
Eran Maman1, Jacob Bickels1, James C Wittig2, Kristen
L. Kellar-Graney2, Yehuda Kollender1, Isaac Meller1, Martin 
Miles Malawer2
1National Unit of Orthopedic Oncology Tel-Aviv Sourasky Medical 
Center, 2Division of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center
Objective: Tumors  of  the  axilla  impose  a  surgical  difficulty
because they are usually large at presentation and in close proxim-
ity  to  the  major  neurovascular  bundle  of  the  upper  extremity.
Attempted tumor resection via the base of the  axilla  is  difficult
because of limitations in full visualization of the lesion and identi-
fication  and  mobilization  of  the  neurovascular  bundle  prior  to
resection. The authors have used a safe and reliable exposure for
these situations.
Methods: Between 1980 and 1997, 35 patients underwent exten-
sile exposure of an axillary tumor. Diagnoses included 19 primary
and 16 metastatic tumors of the axilla. The axillary cavity was fully
exposed via the deltopectoral groove after detachment and reflec-
tion of two layers of muscles: first, the pectoralis major and, sec-
ond, the coracoid origin of the pectoralis minor, coracobrachialis,
and the short head of the biceps muscle. This surgical approach
allowed full  tumor visualization and determination of the  exact
anatomic relation of the tumor to the neurovascular bundle and as
a result,  tumor resectability.  Following resection, the  pectoralis
minor  and  conjoined  tendons  were  reattached  to  the  coracoid
process with a nonabsorbable suture, and the pectoralis major was
reattached to its insertion site on the proximal humerus in the same
manner.CTOS  abstracts S13
Results: Exposure revealed a safe plane of dissection between
the tumor and the major neurovascular bundle in 23 patients and
invasion of the major neurovascular bundle in 12 patients who
subsequently underwent a forequarter amputation. At the most
recent follow-up, none of these patients had functional limita-
tion, which could be attributed to the extensile approach itself.
All patients gained their presurgical pectoralis major and biceps
function. Complications in the group of patients that underwent
tumor resection included three (13%) superficial wound infec-
tions. Due to intended, enbloc resection  of  an involved nerve
with  the  tumor,  two  nerve  palsies  (8.7%)  were  documented.
None of the remaining 21 patients had numbness, paresthesias,
or nerve pain. There were three  (13%) local recurrences; two
were managed with wide excision and adjuvant radiation therapy
and one necessitated amputation.
Conclusion: The extensile exposure of the axilla allows full visual-
ization of axillary tumors. It allows determination of tumor resecta-
bility  and  safe  and  reliable  resection,  when  indicated.  This
exposure  is  associated  with  good  functional  outcome  and  an
acceptable morbidity. The extensile  axillary exposure is  recom-
mended in the management of axillary tumors.
019 Enchondroma of the Hand: Management with 
Curettage and Cemented Intramedullary Hardware
Jacob Bickels1, James C. Wittig2, Yehuda Kollender1, Kari 
L Mansour2, Isaac Meller1, Martin M Malawer2
1Tel-Aviv Sourasky Medical Center National Unit of Orthopedic 
Oncology, 2Division of Orthopedic Oncology Washington Cancer 
Institute Washington Hospital Center
Objective: Surgical removal by means of curettage is the mainstay
of treatment  of enchondromas of the  hand. Methods of recon-
struction after tumor removal usually entail no reconstruction or
filling  of the  tumor cavity with  a  bone graft. These  techniques
necessitate  a  prolonged  period  of  protected  activity  until  bone
healing of the tumor cavity occurs. The authors have utilized hard-
ware and bone cement for the purpose of reconstruction of the
tumor cavity. This technique provides immediate mechanical sta-
bility and allows early mobilization.
Methods: Between 1986 and 1999 the authors treated 13 patients
(8  females,  4  males)  who  ranged  in  age  from  23  to  58  years
(median, 32 years) and diagnosed with enchondroma of the hand.
Eight  patients  presented with a pathological fracture. Anatomic
locations included: metacarpal bones – 5, proximal phalanx – 4,
and middle phalanx – 4. Tumors were approached through the
retained thinned or destroyed cortex to minimize additional bone
loss.  Surgery  included  removal  of  all  gross  tumors  with  hand
curettes; this was followed by high-speed burr drilling of the inner
reactive bone shell. Reconstruction included intramedullary metal
wire along the longitudinal axis of the cavity and polymehylmeth-
acrylate (PMMA). Full activity as tolerated was allowed immedi-
ately  after  surgery. All  patients  were  followed  for  more than  2
years; Follow-up included physical and radiological evaluation and
functional evaluation.
Results: Following surgery, all patients returned to their presurgi-
cal functional capability within two weeks. At the last follow-up,
none of the patients had local tumor recurrence and although three
patients had 15° to 20° decrease in flexion of the metacarpophalan-
geal joint, none reported a functional limitation. There were no
postoperative infections or fractures.
Conclusion: Reconstruction of the tumor cavity, remaining after
curettage of enchondroma of the hand, with intramedullary hard-
ware and PMMA provides  immediate  mechanical  stability  and
allows early mobilization. This technique is associated with good
short- and long-term functional outcomes.
020 Distal Femur Resection with Endoprosthetic 
Reconstruction: A Long Term Follow-Up Study
Jacob Bickels1, James C Wittig2, Yehuda Kollender1, Robert 
M Henshaw2, Robert S Neff2, Isaac Meller1, Martin M Malawer2
1National Unit of Orthopedic Oncology Tel-Aviv Sourasky Medical 
Center, 2Division of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center
Objective: The  distal  femur is  a common  site  for primary  and
metastatic bone tumors. It is, therefore, a frequent site in which to
perform a limb-sparing surgery. The authors describe their experi-
ence with distal femur resection and endoprosthetic reconstruction
Methods: There were 61 males and 49 females who ranged in age
from 10 to 80 years. Nineteen patients were younger than 12 years
of  age.  Diagnoses  included  99  malignant  tumors  of  bone,  9
benign-aggressive  lesions,  and 2  non-neoplastic  conditions  that
had  caused  massive  bone  loss  or  articular  surface  destruction.
Endoprosthetic reconstruction included 73 modular, 27 custom-
made, and 10 expandable prostheses. Only eight patients had a
constrained knee mechanism; the remaining patients underwent
reconstruction with a rotating-hinge knee mechanism. All prosthe-
ses  were  fixed  with  bone  cement.  Soft-tissue  reconstruction
included  21  medial,  3  lateral,  and  one  bilateral  gastrocnemius
flaps. All patients were followed for more than 2 years (range, 2-
16.5 years; average, 5.2 years); Follow-up included physical and
radiological evaluation and functional evaluation according to the
American Musculoskeletal Tumor Society System.
Results: Function  was  estimated  to  be  good or  excellent  in  94
patients (85.4%), moderate in 9  patients  (8.2%), and poor in 7
patients  (6.4%).  Patients  who  underwent  reconstruction  with  a
rotating-hinge knee mechanism were more likely to have a good-to-
excellent  functional  outcome  (91%)  than  those  who  underwent
reconstruction with a constrained knee mechanism (50%). Compli-
cations included six deep wound infections (5.4%), which resulted
in three amputations, two prosthetic revisions, and one wound deb-
ridement.  There  were  six  local  recurrences,  five  of  which  were
treated with wide local excision, and one necessitated amputation.
Overall, there were 14 revision surgeries; these included replace-
ment of failed polyethylene component in 6 patients and prosthetic
revision in 8 patients (aseptic loosening – 5; deep infection – 2; and
radiation bone necrosis –1). There were six local recurrences, five of
which were treated with wide local excision, and one necessitated
amputation. Prosthetic survival was 94% at 5 years and 91% at 10
years and overall limb salvage rate was, therefore, 96%.
Conclusion: Distal  femur  resection  with  endoprosthetic  recon-
struction  is  a safe and reliable  procedure, which provides good
local tumor control. The use of cemented endoprostheses, com-
bined with a rotating-hinge knee mechanism provide immediate
mechanical stability, allows early mobilization and good-to-excel-
lent function in most patients. The use of endoprostheses is recom-
mended  by  the  authors  for  reconstruction  of  large  segmental
defects of the distal femur. Distal femur resection with endopros-
thetic reconstruction is a safe and reliable procedure, which pro-
vides  good  local  tumor  control.  The  use  of  cemented
endoprostheses, combined with a rotating-hinge knee mechanism
provide immediate mechanical stability, allows early mobilization
and good-to-excellent function in most patients. The use of endo-
prostheses is recommended by the authors for reconstruction of
large segmental defects of the distal femur.
021 Constrained (Rotator Cuff Substituting) Total Scapula 
Prosthesis: “Anatomic” Approach for Reconstructing the 
Shoulder Girdle following High-Grade Sarcoma Resection
James C Wittig1, Jacob Bickels2, Felasfa Wodajo1, Kristen 
L. Kellar-Graney1, Martin M Malawer1
1Division of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center, 2National Unit of Orthopedic Oncology 
Tel-Aviv Sourasky Medical CenterS14 CTOS  abstracts
Objective: High-grade sarcomas arising from the scapula or peris-
capular soft tissues  have traditionally been treated with either a
total  scapulectomy  or  a  wide,  en-bloc,  extraarticular  scapular
resection,  termed  the  “Tikhoff-Linberg”  resection.  The  major
challenge following such resections is to restore shoulder girdle sta-
bility while preserving a functional hand and elbow.
Methods: This report describes three patients who underwent an
extraarticular, total scapula resection (modified Tikhoff-Linberg)
for a high-grade sarcoma. Each patient was reconstructed with a
constrained (rotator cuff substituting) total scapula prosthesis in
an effort to optimally restore the normal muscle force couples of
both glenohumeral and scapulothoracic mechanisms.
Results: At latest follow-up, the MSTS functional score was 24-
27/30 (80%–90%). All patients had a stable, painless shoulder and
functional hand and elbow. Glenohumeral rotation below shoulder
level, shoulder extension and abduction were preserved. Protrac-
tion,  retraction,  elevation  and  abduction  of  the  scapula  were
restored  and participated  in  active  shoulder  motion  and upper
extremity stabilization. There were no complications.
Conclusion: Total scapula reconstruction with a constrained total
scapula prosthesis is a safe and reliable method for reconstructing
the shoulder girdle following resection of select high-grade sarco-
mas.  This  report  emphasizes  the  clinical  indications, prosthetic
design, surgical technique and early functional results.
024 Osteosarcoma of the Proximal Humerus: Long Term 
Results with Limb Sparing Surgery
James C Wittig1, Jacob Bickels2, Kristen L. Kellar-Graney1, Isaac 
Meller2, Martin M Malawer1
1Division of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center, 2National Unit of Orthopedic Oncology 
Tel-Aviv Sourasky Medical Center
Objective: The purpose of this study was to analyze the long-term
oncological and functional results  and complications  associated
with limb-sparing surgery and endoprosthetic reconstruction for
23 patients with osteosarcoma of the proximal humerus.
Methods: There were 1 stage IIA lesion, 18 stage IIB lesions, and 4
stage  III  lesions  in  this  study  group.  Twenty-two  patients  were
treated with an extraarticular resection that included the deltoid and
rotator cuff and one patient was treated with an intraarticular resec-
tion that spared the shoulder abductors. In all these patients, the
proximal humerus was reconstructed with a cemented endopros-
thetic replacement that was stabilized via a technique of static sus-
pension (Dacron tapes) and dynamic suspension (muscle transfers).
Results: At latest follow-up (median: 10 years), 15 patients (65%)
were alive without evidence of disease. There were no local recur-
rences. Prosthetic  survival was 100% for the  15  survivors. The
Musculoskeletal Tumor Society (MSTS) upper extremity  func-
tional score ranged from 24 to 27 (80%–90%). All shoulders were
stable and pain-free. Elbow and hand function were preserved in
all patients. The most common complication was a transient neu-
ropraxia (n=8).
Conclusion: En-bloc extraarticular resection and endoprosthetic
reconstruction is a safe and reliable method of limb-sparing sur-
gery for high-grade extracompartmental osteosarcoma of the prox-
imal humerus.
026 Alveolar Soft Part Sarcoma: A Report of 15 Cases
Serge van Ruth, Frits van Coevorden, Bin B.R. Kroon
Department of Surgical Oncology Netherlands Cancer Institute, 
Amsterdam NL
Objective: Alveolar soft part sarcoma is rare tumour representing
0.5–0.9% of all soft tissue sarcomas in adults and 0.8–1.85 of those
in children. Published series on presentation and treatment out-
come of this sarcoma are scarce. Long-term survival is doubted in
most reports. We present our experience with 15 cases, with six,
and among them three long-term survivors.
Methods: Between 1971 and 2000 15 patients with alveolar soft
part sarcoma were headed in our hospital. We collected the files
and described their characteristics, therapy and course.
Results: The study group consisted of 8 male patients with a mean
age at diagnosis of 29 years and 7 female patients with a mean age
of 24 years. The primary site was the lower extremity (n=8), but-
tock (n=2), abdominal wall (n=1), axilla (n=1) and temple (n=1).
The median follow-up was 170 (2–370) months. The median sur-
vival was 48 months with an overall 5-year survival of 38%. At time
of diagnosis 5 patients already had metastases, all pulmonary local-
ized. 5 patients developed early metastases  at follow-up, after a
tumor  free  interval  of  respectively  1,  1,  2,  8  and  12  months.
Median  survival  after  diagnosis  of  metastases  was  29  (1–111)
months. One is alive with evidence of disease, the other 8 died of
their  disease.  One patient  with  metastatic  disease  died after an
unexpected long survival (111 months) under various treatment
schedules. Another patient with a local recurrence underwent sur-
gery and adjuvant radiotherapy; she is still alive with no evidence
of  disease,  295  months  after  the  initial  diagnosis.  Four  other
patients  are  alive  without  disease  after  12,  12,  234  and  242
months. In this study chemotherapy influenced the course of the
disease only incidentally.
Conclusion: Alveolar  soft  part  sarcoma  is  found  especially  in
young adults. When diagnosed it is often metastasized with a poor
prognosis. However, with adequate local treatment, long-term sur-
vival is possible.
029 Surgical Resection, Vascular Reconstruction, and 
Postoperative Radiation for Leiomyosarcoma of the 
Inferior Vena Cava
Fritz Christian Eilber, Gerald Rosen, Michael Selch, Scott Nelson, 
William Quinones, Frederick Richard Eilber
Divisions of Surgical Oncology, Medical Oncology, Radiation 
Oncology, Surgical Pathology and Vascular Surgery, University of 
California Los Angeles
Objective: Surgical resection for leiomyosarcoma of the inferior
vena cava has been minimally effective due to the technical diffi-
culties of surgery, postoperative morbidity, and poor overall sur-
vival. The purpose of this  study was to determine  if  aggressive
multimodality  therapy  for  leiomyosarcoma  of  the  inferior  vena
cava would provide survival rates comparable to non-vena caval
leiomyosarcomas of the retroperitoneum.
Methods: From 1983 to 2000 22 patients with primary leiomy-
osarcoma of the inferior vena cava were evaluated for multimodal-
ity treatment consisting of complete surgical resection, immediate
vascular reconstruction of the inferior vena cava and postoperative
radiation therapy. Treatment results were reviewed and compared
to 41 patients with non-vena caval leiomyosaromas of the retroper-
itoneum treated at the same institution.
Results: Nineteen patients (19/22, 86%) successfully underwent
complete  surgical  resection  with  vascular  reconstruction  of  the
vena cava. The remaining three (3/22, 14%) patients were unre-
sectable due to aorto-mesenteric involvement and died of their dis-
ease  within  14  months  of  evaluation.  Seventeen  of  the  19
resectable patients (17/19, 89%) received postoperative radiation
and two patients (2/19, 11%) did not. Local tumor control was
achieved in 16 of the 17 patients (16/17, 94%) who received post-
operative radiation but in neither of the two patients that did not.
With a mean follow up of 52 months, the overall survival for the 19
resectable patents was 82% at one year, 53% at three years and
44% at five years. These results are comparable to the 85 % one
year, 62% three year and 40% five year survival rate for the 41
patients with non-vena caval leiomyosarcoma of the retroperito-
neum treated at the same institution.CTOS  abstracts S15
Conclusion: Complete surgical resection with immediate vascular
reconstruction for leiomyosarcoma of the inferior vena cava was
achievable in 86% of the cases. This aggressive surgical approach
combined with postoperative radiation therapy can provide sur-
vival rates similar to non-vena caval leiomyosarcomas of the retro-
peritoneum and thus provides a successful treatment strategy for a
rarely treated malignancy.
033 Limb-Sparing Endoprosthetic Reconstruction following 
Major Oncologic Musculoskeletal Resections: Improved 
Long Term Results and Quality of Life with a Modular 
System
Robert M Henshaw, Kristen L. Kellar-Graney, Martin 
M Malawer
Division of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center
Objective: Reconstruction of segmental skeletal defects following
major resections for sarcoma remains a technically demanding pro-
cedure. A modular replacement system (MRS, Pfizer/Howmedica
Inc.) was designed as a flexible off-the-shelf solution for resections
of the proximal humerus (PH), proximal femur (PF), distal femur
(DF), total femur (TF) and proximal tibia (PT). Implant assembly
at surgery provides an optimal fit for the bone defect. This study
reviews the long-term clinical outcome and prosthetic survival of
this system.
Methods: 100 consecutive cases since 1986 were retrospectively
analyzed. Standard Kaplan-Meier analysis was used to determine
prosthetic  survival. Failure was defined as any event leading to
removal of the implant.
Results: Median f/u was 77.8 months (min 2 yrs). Dx at surgery:
72 primary bone sarcomas, 11 metastatic carcinomas, 11 revisions
of failed allografts or prior reconstructions, 4  benign aggressive
bone tumors, 1 myeloma and 1 lymphoma. Procedures performed:
48  distal  femoral  replacements,  22  proximal  humeral  replace-
ments,  15  proximal  femoral  replacements,  13  proximal  tibial
replacements and 2 total femoral replacements. Age at surgery: 8
to 78 years. No mechanical failures of the stems, bodies, or inter-
locking tapers occurred. The ultimate limb-salvage rate was 93%
while the infection rate was 8%. Both rates compare very favorably
with outcomes associated with other methods of skeletal recon-
struction for this patient population. Kaplan-Meier survival analy-
sis  of  all  implants  at  median  f/u  of  6.5  yrs  was  90.5%
[95%CI:0.83%–0.98%].  Survival rates of implants by anatomic
sites were: DF 90.3% at median f/u of 76.5 months, PH 95.4% at
91.2 months, PF 100% at 72.2 months, PT 75.1% at 72.2 months,
and TF 100% at 38.8 months.
Conclusion: Long-term survival and limb salvage rates using the
MRS exceeds that reported for allografts, custom endoprostheses,
and other modular systems. This system sets a new standard for
limb sparing reconstruction following major sarcoma resections as
well as allowing limb salvage of failed massive allografts or custom
endoprostheses.
034 Regional Postoperative Analgesia via Indwelling 
Epineural Catheters Following Major Limb Sparing 
Resections and Amputations: Analysis of 166 Patients
Naveh Levy, Robert M Henshaw, Kristen L. Kellar-Graney, 
Martin M Malawer
Division of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center
Objective: Continuous postoperative administration of local anes-
thetics through epineural catheters (surgically implanted within a
peripheral nerve sheath, or epineural space) is a novel technique
for obtaining regional pain control developed by the senior author
over a decade ago. The purpose of this study was to document the
safety, efficacy, and reliability of this technique used at a single
institution.
Methods: Retrospective analysis of 166 pts (median age 45.8 yrs,
86  male/81  female)  undergoing  limb-saving  resection  (119),
amputation (31), or other major surgical procedure (16) who were
implanted with one or more epineural catheters prior to wound
closure. Actual nerves implanted with catheters included: sciatic
(110), femoral (38), brachial plexus (29), tibial (11), perioneal (7),
lumbosacral plexus (4), obdurator (2), median (2), ulnar (1), and
tarsal  tunnel  (1).  Following  implantation,  each  catheter  was
bolused with 10 cc of 0.25% bupivacaine (Marcaine) to achieve an
initial block, then continuously infused with bupivacaine for a min-
imum of 24 hours to a maximum of 21 days post-operatively. 112
pts  had  complete  medication  records  and  were  divided  into
groups:  Group 1  pts  (34) received  an epineural catheter,  PCA
pump, and a lumbar epidural catheter (triple modality pain con-
trol), while Group 2 pts (78) received only an epineural catheter
and PCA pump (dual modality pain control). The total amount of
narcotics used postoperatively (expressed in mg equivalents of IV
morphine), and the verbal mean pain rating (MPR) were recorded.
Results: Average MPR and total narcotic use for Group 1 was 2.9
and 320 vs. 3.2 and 240 for Group 2. There were no local compli-
cations, i.e. infections, hematomas, or residual neurologic losses,
attributable to the implantation or use of epineural catheters. 3
catheters broke at the skin level while being removed; 2 of these
catheter tips were removed at bedside while 1 was left in situ. 3
catheters were unintentionally pulled out as a result of pt move-
ment. One patient inadvertently died following unintentional infu-
sion of a marcaine dosage though an IV line instead of the catheter.
Conclusion: (1)  The  use  of  epineural  catheters  following  limb
sparing or ablative surgery provides dramatic postoperative analge-
sia comparable to that seen in pts with epidurals. (2) This tech-
nique is simpler, safer and more reliable than epidural catheters
without any risk for epidural hematoma, abcess, or spinal leak, par-
ticularly in pts who have recently received chemotherapy. (3) We
recommend epineural catheters as a primary mode of postopera-
tive pain control following major resections and amputations at the
pelvic, shoulder girdle level as well at the hip and knee joint.
039 The Concept of a Gluteal (Buttock) Compartment: 
Radiopathological Considerations, Indications, and 
Surgical Technique of Resection
James C Wittig1, Felasfa Wodajo1, Jacob Bickels2, Yehuda 
Kollender2, Kristen L Kellar-Graney1, Robert M Henshaw2,
Isaac Meller2, Martin M Malawer1
1Division of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center, 2National Unit of Orthopedic Oncology 
Tel-Aviv Sourasky Medical Center
Objective: This study reports our guidelines for limb-sparing sur-
gical resection of gluteus maximus tumors in lieu of hemipelvec-
tomy and presents our oncological functional results. The concept
of a buttock compartment is presented with its unique pathologic
and radiologic considerations.
Methods: Between 1991 and 2001, 13 patients were treated (7
males,  6  females)  with  buttock  resection.  Histology  included:
liposarcoma (5), leiomyosarcoma (3), MFH (1), fibromatosis (2),
and myxoma  (2).  Median  tumor  size  was  10  cm.  Six  patients
received adjuvant chemotherapy or radiation. Surgical resection
was performed through a curvilinear  incision  in the  shape of a
question mark. The sciatic nerve was explored early and frozen
section biopsy performed through its fascial sheath. The inferior
gluteal vessels and branches of the superior gluteal vessels were
ligated at the level of the sciatic notch and the gluteus maximus was
resected en bloc.S16 CTOS  abstracts
Results: The  follow-up  ranged  from  2  months  to  80  months
(mean: 30.5 months). There were no local recurrences. Three
patients died of metastatic disease. Pathological analysis demon-
strated the sciatic nerve sheath to be free of tumor and the deep
fascia  of the  gluteus  maximus  to  be  intact  in  all  patients.  All
patients were ambulatory without assistance. No patient reported
compromise in functional activities. Two patients complained of
pain when sitting on hard surfaces for prolonged periods of time.
Complications  included  Skin  Flap  Necrosis  (partial)  in  4
patients.
Conclusion: Surgical resection of the buttock is a safe and reliable
surgical option for treatment of selected soft-tissue tumors arising
from the gluteus maximus. Gluteus maximus tumors can grow to
large sizes but remain contained within the investing fascia of the
muscle, thus facilitating compartmental resection by single myec-
tomy. There is minimal functional loss following resection of the
gluteus maximus.
048 The Influence of Anatomical Location on Outcome in 
Extremity Soft Tissue Sarcoma
C H Gerrand4, R S Bell2, J S Wunder1, R A Kandel1, 
B O’Sullivan2, C N Catton2, A M Griffin1, A M Davis3
1University Musculoskeletal Oncology Unit, Mount Sinai Hospital and 
the University of Toronto, 2Princess Margaret Hospital of the University 
Health Network, 3Toronto Rehabilitation Institute and University of 
Toronto, 4North of England Bone and Soft Tissue Tumour Service, 
Freeman Hospital
Objective: To  determine  if  the  rates  of  local  recurrence  and
metastasis differ in upper versus lower extremity sarcomas.
Methods: Prospectively  collected  data  relating  to  patients  who
underwent limb-sparing surgery for extremity soft tissue sarcoma
between January 1986 and April 1997 were analysed. The local
recurrence-free and metastasis-free rates were calculated using the
method of Kaplan and Meier. Univariate and multivariate analyses
of potential predictive factors were evaluated with the log-rank test
and the Cox proportional hazards model.
Results: Of 480 eligible patients, 48 (10.0%) had a local recur-
rence  and  131  (27.3%)  developed  metastases.  The  median
follow-up of survivors was 4.8 years (0.1 to 12.9). There were
139  upper  and 341  lower  extremity  tumors.  Upper  extremity
tumors  were more often treated by unplanned excision  before
referral  than  lower  extremity  sarcomas  (89  (64.0%)  vs.  160
(46.9%), p=0.001) and were smaller (6.0cm vs 9.3cm, p=0.000).
Lower extremity tumors were more often deep to or involving the
investing fascia (280 (82.9%) vs. 97 (69.8%), p=0.003). The dis-
tribution of histological types differed in each extremity. Fewer
upper extremity tumors were treated with adjuvant radiotherapy
(98 (70.5%) vs. 289 (84.8%), p=0.000). The local recurrence-
free rate at five years was 82% in the upper and 93% in the lower
extremity (p=0.002). Local recurrence in the Cox model was pre-
dicted by surgical margin status (hazard ratio 3.16, p=0.000) but
not extremity  (p=0.127) or unplanned excision  before referral
(p=0.868). The metastasis-free rate at five years was 82% in the
upper and 69% in the lower extremity (p=0.013). Metastasis was
predicted  by  high  histological  grade  (hazard  ratio  17.28,
p=0.000), tumor size  in cm  (hazard ratio 1.05, p=0.001)  and
deep location (hazard ratio 1.93, p=0.028) but not by extremity
(p=0.211).
Conclusion: Local recurrence is more frequent after treatment for
upper compared with lower extremity sarcomas. Variation in the
use of radiotherapy and differences in histological type may be con-
tributory. Metastasis  is  more frequent after treatment  for lower
extremity sarcomas because tumors tend to be large and deep com-
pared with upper extremity tumors.
053 Curettage Resection and Cryosurgery for Extremity 
Low Grade Chondrosarcoma
Felasfa Wodajo, Kari L Mansour, James C Wittig, Frank H Kim, 
Robert M Henshaw, Martin M Malawer
Department of Orthopedic Oncology Washington Cancer Institute 
Washington Hospital Center
Objective: Previously  reported  treatments  for  low-grade  chon-
droid tumors have ranged from simple curettage to wide resection
to even amputation. Curettage resection for cartilage tumors, while
attractive for being associated with less morbidity than resection
has been criticized as leading to higher recurrence rates. For the
past 13 years, we have used cryosurgery as an adjunct to curettage
to eradicate residual microscopic disease in an effort to improve
local tumor control over curettage alone. The purpose of this study
is to report the oncological and functional outcome of extremity
low grade chondrosarcoma treated with consistent surgical indica-
tions and techniques.
Methods: Curettage resection for cartilage tumors, while attrac-
tive  for being associated with  less  morbidity  than resection  has
been criticized as leading to higher recurrence rates. We have used
cryosurgery as an adjunct to curettage to eradicate residual micro-
scopic  disease  in an effort to improve local tumor control over
curettage alone. The purpose of this study is to report the oncolog-
ical and functional outcome of extremity low grade chondrosar-
coma treated with curettage, cryosurgery and cemented internal
fixation.
Results: Average length of follow-up was 73 months (range 25–
161 months). There were no local recurrences or distant metas-
tases. Functional results in the proximal humerus were as follows:
14/23  good  (i.e.  minimal  pain  and/or  minimal  limitation  of
motion), 6/23 excellent (no pain, normal range of motion) and 3/
23 fair. In the distal femur, outcomes were 2/16 excellent, 13/16
good  and  1/16  fair.  Complications  included  one  70  year-old
patient who had late (3 year) post-operative degenerative changes
of  the  shoulder underwent shoulder  arthroplasty. One non-dis-
placed unicortical fracture in the distal femur was treated success-
fully  without  immobilization.  There  was  one  case  of  reflex
sympathetic dystrophy of the upper extremity which resolved with
sympathetic blockage.
Conclusion: Curettage  resection  and cryosurgery for  low  grade
chondrosarcoma, if applied according to strict patient selection cri-
teria and followed by appropriate reconstructive techniques allows
for preservation of near-normal limb function with minimal rates of
complications and recurrence. We do not recommend en bloc resec-
tion for the treatment of low grade extremity chondrosarcoma.
058 Excisional Biopsy Prior to Wide Resection of Extremity 
Sarcoma is Associated with Improved Outcome
Mark D. McKee1, Brian P. Whooley2, Deborah Driscoll1, John 
F. Gibbs1, William G. Kraybill1
1Roswell Park Cancer Institute, 2Saint Vincent’s Hospital and Medical 
Center
Objective: Needle or incisional biopsies are preferred over exci-
sional biopsy for suspected sarcoma since they are limited proce-
dures, they minimize the amount of surrounding tissue exposed to
tumor, and the sites are easily encompassed at the time of wide
resection.  Sarcoma  treatment  by  definitive  wide  resection  after
excisional  biopsy (re-resection) has been reported  to independ-
ently predict freedom from distant metastases and improved over-
all survival. We evaluated patients undergoing surgery for sarcoma
to determine the influence of excisional biopsy and re-resection on
patient outcome.
Methods: Clinical factors, pathologic factors, and outcome were
determined  for  202  patients  who  were  surgically  treated  for
extremity soft tissue sarcoma between 1982 and 1998. Outcomes
were  measured  for  patients  undergoing  definitive  surgery  afterCTOS  abstracts S17
excisional  biopsy  (re-resection)  or  definitive  surgery  after  inci-
sional, needle, or no biopsy (single resection).
Results: Tumors  were  predominantly  high-grade  (148/196),
larger  or equal to 5cm  in  size  (142/200),  deep  (166/202),  and
located on the  lower limb  (145/202). Treatment included wide
local excision, compartment resection, or amputation. Final resec-
tion margins were negative for 190/202. Patient / tumor factors:
Patients  who  underwent  re-resection  were  more  likely  to  have
small tumors, superficial tumors, upper extremity tumors, and be
of younger age. Gender, duration of symptoms, tumor grade, his-
tology, and resection margin were no different between groups.
Outcome: Recurrence and survival by group are shown in the table
below.  Margin  status  after  excisional  biopsy  did  not  influence
patient  outcome.  Multivariate  analysis:  Factors  associated  with
improved  overall  survival  (OS)  by  univariate  analysis  included
young  patient  age  (p<.001),  low  tumor  grade  (p<.001),  small
tumor size (p<.01), superficial location (p<.05), and re-resection
(p<.001). By multivariate analysis, improved disease-free survival
(DFS) was predicted by low tumor grade (p<.01) and re-resection
(p<.05). Improved OS was predicted by low tumor grade (p<.01)
and re-resection (p<.001).
Conclusion: Re-resection following excisional biopsy for extrem-
ity sarcoma independently predicted freedom from distant recur-
rence and improved survival. These results were unexpected, and
could not be entirely explained by differences in clinico-pathologic
features between the groups. The biologic reasons for improved
outcome among patients undergoing re-resection are not clear.
065 The Value of Population Based Research in Soft Tissue 
Sarcoma (STS)
Chris J de Gara, Juanita Hatcher, Doug Dover, George Dundas, 
Guy Lavoie, Robert Turner
The Cross Cancer Instiute, University of Alberta
Objective: Because of the heterogeneity and rarity of STS, Level
I evidence is largely lacking and this results in a variety of treatment
approaches.  Population  Based  Outcomes  Research  may  be  of
value in STS management as it is generalizable, includes and fol-
lows all patients and avoids the selection, referrer and other biases
inherent in case series and even randomized study.
Methods: The Alberta Cancer Registry, by law, registers all can-
cers including STS, patient demographics, tumour and treatment
details and overall survival. There are two Regional Cancer Cen-
tres (Tom Baker in Southern Alberta population 1.3M and the
Cross Cancer Institute in Northern Alberta population 1.7M).
Results: Between 1990 and 1999, 380 patients (53% male; 211
Northern and 169 Southern) over the age of 18 years (mean 56 +
18 years) were diagnosed with STS. The most common tumours
were MFH (30%), sarcoma NOS (27%), leiomyosarcoma (16%)
and liposarcoma (15%) with  no  significant  differences between
centres. Other than pelvis n = 33 (Northern) vs. 16 (Southern) p
= 0.01 and trunk n = 17 (Northern) vs. 6 (Southern) p = 0.02,
tumour location was similar  in Northern and Southern Alberta.
Northern  Alberta  coded significantly  more high  grade  tumours
(41%) than Southern Alberta (18%) p 0.01. Significant treatment
differences existed between Northern and Southern Alberta: sur-
gery + radiation + chemotherapy 5% vs. 38% p 0.0001, surgery +
radiation 30% vs. 11% p 0.0001, and surgery alone 46% vs. 29%
p 0.0001. These differences did not result in survival differences.
For limb, 5 year survival was 69% (Northern) vs. 66% (Southern)
and for non-limb was 56% (Northern) vs. 52% (Southern). These
differences were not significant. For the province as a whole the
overall 5 year non-limb survival was 54% vs. limb 67% p = 0.0072.
Conclusion: In summary, using a population based approach to
the assessment of STS within a province, differences in treatment
and tumour grade were not associated with overall survival differ-
ences. While local recurrence and quality of life data are not yet
available, we concluded that this approach can provide valuable
insights into the management of this complex cancer.
068 Atypical Lipomas of the Extremities
Tamara Rosenthal, Lisa Khoury, Rakesh Donthineni-Rao, 
Richard Lackman
Department of Orthopaedics, University of Pennsylvania
Objective: Atypical lipomatous tumors also known as well differ-
entiated  liposarcomas  occur  predominantly  in  middle-aged
patients and often present to the orthopaedic surgeon as painless,
slow-to-moderately fast  growing masses  in the  extremities.  The
purpose of this study is to describe the natural history and treat-
ment outcome of 31 patients with superficial or deep atypical lipo-
mas of the extremities.
Methods: The records of patients treated for atypical lipomas of
the extremities were reviewed. Criteria for inclusion were a diagno-
sis of superficial or deep atypical lipomas made by surgical pathol-
ogy, as well as a minimum follow-up of one year from the time of
original diagnosis.
Results: Thirty-one patients  met  the  inclusion criteria  for this
study. There were 16 males and 15 females, with an average age
of 57 years at the time of the initial presentation (range 32–87
years). Mean follow-up was 7 years (range 1–28.8 years). At pres-
entation,  19  patients  reported  a  slowly  growing  mass  and  12
patients reported pain as the initial symptom. Twenty-five tumors
occurred in the lower extremity and 6 in the upper extremity. Six-
teen patients (52%) had a recurrence at an average of 4.7 years
after resection (range 2 months–10 years). Twelve (39%) patients
required additional surgical procedures to treat their tumor. Ded-
ifferentiation  to  high-grade  liposarcoma  developed  in  three
patients (10%). These were treated with resection and radiation
with  or  without  chemotherapy,  and  are  disease  free  at  latest
follow-up.
Conclusion: Atypical lipomas, whether deep or superficial, have a
high propensity for local recurrence and a potential for malignant
dedifferentiation. These tumors  thus  require careful evaluation,
adequate surgical treatment and close clinical follow-up extending
beyond five years.
069 Epithelioid Sarcoma: Clinical Behaviour of a Rare Soft 
Tissue Sarcoma
Dario Baratti, Alessandro Gronchi, Paolo Casali, Laura Lozza, 
Elisabetta Pennacchioli, Rossella Bertulli, Palma Dileo, Mario 
Santinami
Istituto Nazionale per la Cura e lo Studio dei Tumori
Objective: Epithelioid sarcoma (ES) is a rare subtype of soft tissue
sarcoma (STS). Distinctive clinical features have a tendency to be
multifocal at presentation and to spread locally at recurrence, with
an higher rate of lymph nodes involvement and in-transit metasta-
sis.
Methods: Twenty-nine  consecutive  patients  with  ES  were
observed at our institution from June 1985 to June 2001. Twenty-
two were male and 7 female; median age at the time of first diag-
nosis was 29 years (range 9–66). Site of first presentation was the
hand in 12 cases, the upper limb in 5, the foot in 2, the lower limb
in 6 and the trunk in 4. Fourteen out of 29 patients referred after
a median of 3 consecutive relapses (range 1–5), developing multi-
focal recurrences in 4 cases, loco-regional nodal involvement in 2
N LR (p=NS) DR (p<.001) 5 yr DFS (p<.001)5 yr OS (p<.001)
Re-resection 109 17 (16%) 26 (24%) 60% 72%
Single resection 93 18 (19%) 43 (46%) 26% 48%S18 CTOS  abstracts
and distant metastasis in 1. Two patients underwent amputative
surgery before our observation. Primary treatment of choice per-
formed in our department was wide en-bloc excision, with the aim
to obtain adequate margin of uninvolved tissue in all directions,
and to spare limbs and limb function as much as possible. Adju-
vant RT was administered to high risk patients in a postoperative
fashion.
Results: ES presented as small superficial nodules in 18 cases and
this feature was prevalent in distal localization (11/14), while deep-
seated larger masses were more common in the proximal extremi-
ties or in the trunk (8/15). Surgical treatments performed were:
wide excision in 15 patients, re-excision in 8, digit or ray amputa-
tion in 3, major amputation in 3. Surgical margins were rated as
wide in 16  patients  and marginal  in 5. No residual tumor was
found in any patient who underwent re-excision. Adjuvant thera-
pies were the following: postoperative RT in 8 patients, preopera-
tive limb perfusion in 5, preoperative conventional CT in 4 and
postoperative  CT in 1.  Median follow-up  of  the  series  was  32
months (range 3–181). Actuarial overall survival at five years was
76.5%; disease free survival at the same interval was 55.8%. Fol-
lowing  treatment  at  our  Institution,  from  1  to  4  consecutive
relapses (median 2) occurred in 12 patients. Recurrence involved
loco-regional  lymph  nodes  in  five  more  patients,  thus  overall
lymph nodal involvement rate was 7 out of 29 (24.1%). Distant
metastases were detected at the time of first presentation in one
case, developed as first recurrence in two and was subsequent to
nodal involvement in six. Most common site of distant metastati-
zation was the lung. All the patients with metastatic disease have
died. Four more amputations were needed to treat local recur-
rence, thus a total number of 12 such procedures were performed
in  8  patients.  Relapse  occurred in  3  out  of  15  (20%)  patients
treated by primitive neoplasm and in 9 out of 14 (64.3%) treated
for recurrent tumor.
Conclusion: Epithelioid sarcoma is a rare neoplasm, accounting
for less  than 1%  (29/3376) of all  the  STS observed during the
period of the study. The present study showed a great propensity
to recur repeatedly and an high rate of nodal involvement was con-
firmed. Lack of local control lead to an increase in amputation rate.
Adequacy of treatment was the most relevant prognostic factor,
since  patients  referred  for  recurrent  disease,  after  repeated
attempts of local control, had a worse outcome than patients that
underwent primary treatment in our department.
079 Two Hundred and Seven Extra-Abdominal Aggressive 
Fibromatosis Treated at a Single Institution: An Analysis of 
Outcome.
Alessandro Gronchi1, Dario Baratti1, Elisabetta Pennacchioli1, 
Luigi Mariani2, Salvatore Lo Vullo2, Laura Lozza3, Maurizio 
Colecchia4, Paolo Casali5, Rossella Bertulli5, Mario Santinami1 
1Dept. of Muscolo-skeletal surgery. Istituto Nazionale per lo studio e la 
cura dei Tumori., 2Dept. of Biostatistics. Istituto Nazionale per lo studio 
e la cura dei Tumori., 3Dept. of Radiotherapy. Istituto Nazionale per lo 
studio e la cura dei Tumori., 4Dept. of Pathology. Istituto Nazionale per 
lo studio e la cura dei Tumori., 5Dept. of Medical Oncology. Istituto 
Nazionale per lo studio e la cura dei Tumori. 
Objective: Aggressive Fibromatosis (AF) is a rare benign disease,
characterized by a high local failure rate, with possible implication
in quality of life and sometimes even risk of death. A series of 207
patients, treated at our institution over a 30 year span and followed
prospectively, has been reviewed to find out possible predictive cri-
teria of failure. 
Methods: From May 1966 to February 2001 207 pts (median age
36, M/F 51/156), affected by AF (arising from extremities in 41,
girdles in 66, abdominal or chest wall in 56 and from other sites in
44), have been treated at our institution. 131 (median size 5 cm)
presented with primary disease, while 76 (median size 6 cm) had
had at least one local recurrence before being referred. Surgery
alone in 167 patients, while surgery + radiation therapy in 40 (20
for each group) has been the procedure performed at presentation.
Quality of margins was reviewed by a single pathologist and 149
were found to be negative (99 for primary cases and 50 for recur-
rences), while 58 were microscopically positive (32 and 26 respec-
tively). Both univariate and multivariate (Cox model) analyses of
possible prognostic factors were performed. 
Results: During follow-up (median time 85 months) 55 patients
recurred. Four patients died of local progression. The overall sur-
vival was 98% at 5 years and 95% at 10 years, while disease free
survival was 71% at 5 years and 68% at 10 years. Primary cases had
better outcome with 80% disease free survival at 5 years and 74%
at 10 years. Recurrences had 56% disease free survival at 5 years,
stable  up  to  10  years.  In  primary  cases  size  (>  5cm)  and site
(extremities and girdles) were found to be significant prognostic
factors, while quality of margins did not affect outcome. In recur-
rences none of the prognostic factors analyzed were found to be
significant  in  predicting  local  recurrence.  Multivariate  analysis
confirmed the prognostic role of status at presentation (primary
versus recurrence) and size. A borderline P was obtained for site
and there was a suggestion that quality of margins could be prog-
nostic only in recurrences. 
Conclusion: At variance with sarcomas, quality of margins doesn’t
predict outcome in primary tumors. Wide resection is still the cor-
nerstone of treatment, but attempts to achieve negative resection
margins may result in unnecessary morbidity and may not prevent
local recurrence. Operations that preserve function and structure
should be the primary goal, because the presence of residual dis-
ease cannot be clearly shown to impact adversely on 5 years and 10
years disease free or overall survival. Recurrences are at a higher
risk of further recurrence, especially if operated with positive resec-
tion  margins.  Adjuvant  radiation  may  be  delivered  in  selected
cases. 
077 Long Term Follow-Up of Stage IIB Extremity 
Osteosarcoma: The Effect of Local Tumor Extent on 
Prognosis
Jose M Casanova2, Susanne S Spanier1, Robert E Leggon3,
Mark T Scarborough1
1University of Florida, 2Hospitais da Universidade de Coimbra, 
3Geisinger Medical Center
Objective: More recent treatment of osteogenic sarcoma (OGS)
has improved early survival, yet few protocols utilizing surgery and
chemotherapy (chemo) have follow-ups (fu) approaching 20 yrs.
We wished to test the hypotheses that: 1) relapses and treatment-
related deaths occurred 10 years after initial treatment, decreasing
survival; 2) the amount of initial local tumor extension remained a
prognostic factor; and 3) the initial size of the tumor remained a
prognostic factor; all with a fu approaching 20 yrs.
Methods: In 1999 we re-examined the data of 71 pts with high
grade OGS who were treated at the University of Florida from Jan
1, 1979 to Aug 1, 1984. All 71 had surgery, 69 had chemo, and 64
had radiation (59 whole lung, 5 local). 62 of 71  had extremity
lesions. Evaluation included 59 pts with conventional, Stage IIB
OGS of the extremities: 51 followed Protocol (Prot) (surgery, 5
courses of postoperative Adriamycin (total dose of 450 mg/m2),
and 1600 centigray of whole-lung irradiation); 8 did not. Limb sal-
vage surgery was performed in 31% and amputation in 69% of the
Prot pts. Tumor extension was graded E1 to E6 for protocol pts,
and the maximum tumor dimension was recorded. Tumor exten-
sion was E1-E5 (only touching periosteum-invading one structure)
in 26 pts and E6 (invading two or more structures) in 25 pts [ref
1]. The probability of overall survival, according to the Kaplan-
Meier (K-M) method, was plotted for: all pts (n=71); all chemo
pts (n=69); extremity pts (n=62); all  extremity IIB pts  (n=59);CTOS  abstracts S19
Prot pts (n=51); Prot E1-E5 pts (n=26); Prot E6 pts (n=25); non-
extremity pts (n=9); and Prot violators (n=8). K-M curves were
compared using a log-rank test, and survival relative to tumor size
was evaluated with a t-test. [ref 1. Spanier, S.S.; Shuster, J.J.; and
Vander Griend, R.A.: The effect of local extent of the tumor on
prognosis  in  osteosarcoma.  J  Bone  Joint  Surg.,  72-A:643-653,
1990.]
Results: Average fu was 17.4 yrs for survivors. Survival at 5, 10,
15,  and  20  years  was:  66,54,54,52%  for  all  pts  (n=71);
67,55,55,53%  for  all  chemo  pts  (n=69);  64,57,57,57%  for  all
extremity  pts  (n=62);  64,57,57,57%  for  all  extremity  IIB  pts
(n=59); 61,55,55,55% for all Prot pts; 81,73,73,73% for all Prot
E1-E5 pts (n=26); 40,36,36,36% for all Prot E6 pts (n=25); and
78,33,33,22 for non-extremity pts (n=9). A statistically significant
difference in survival remained between groups Protocol E1-E5
and Protocol E6 (p=0.005). Tumor size (av) was 9.4 cm for survi-
vors; 11.6 cm for those dead of disease (p=0.06).
Conclusion: 1)  Few  late  relapses  and  treatment  related  deaths
occurred greater than 10 yrs after initial treatment; 2) the initial
local tumor extension (E1-E5 vs E6) remained a statistically signif-
icant prognostic indicator; while 3) tumor size was only marginally
significant with a fu approaching 20 yrs.
085 Close Surgical Margins in Soft Tissue Sarcoma 
Resection Do Not Predict Local Recurrence When 
Induction (Neoadjuvant) Chemotherapy is used in the 
Treatment of High Grade Extremity Soft Tissue Sarcoma
Felasfa M. Wodajo, James Wittig, Kari Mansour, Dennis Priebat, 
Robert Henshaw, Martin Malawer
Washington Cancer Institute Washington Hospital Center
Objective: Surgical resection with "wide" margins, i.e. with a rim
of normal of tissue, is the mainstay of local control for high grade
soft tissue sarcoma. The objective of this study is to assess whether
the presence of close or microscopically positive surgical margins
contributes  to local recurrence  and what  role,  if  any, induction
chemotherapy without preoperative radiation plays in prevention of
local recurrence after limb-sparing resection of soft tissue sarcomas.
Methods: During  the  period  of 1988  to the  present,  over  100
resections for high-grade soft tissue sarcomas were performed by
the same surgical  team. Of these,  58  whose tumors were deep,
large (more than 5 cm) and high grade were eligible for enrollment
into a chemotherapy protocol consisting of neoadjuvant plus adju-
vant doxorubicin, intra-arterial  cisplatin  and, after 1996, ifosfa-
mide. Patients did not undergo preoperative radiation but those
with poor chemotherapeutic response and close surgical margins
also underwent adjuvant external beam radiotherapy. Twenty nine
patients who underwent their first surgery after induction chemo-
therapy and have follow-up of two years or more form the basis of
this  report.  Pathology reports  from 15  of these  cases  specify  a
margin depth in centimeters.
Results: The overall local recurrence rate was 6.9% (2/29). For the
27  patients  without  local  recurrence,  14  (52%)  have  pathology
reports specifying margin depth. Of these 10/14 (71%) had a mini-
mum distance of less than or equal to 5 mm from the tumor to the
inked margin whereas 1/14 (7%) had a "positive" margin, where
tumor is focally present at the inked margin. Among the 2 patients
with local recurrence, 1 (50%) has a pathology report specifying the
margin depth which was less  than or equal to 5  mm.  Pathology
reports not specifying margin depth stated generally that the margins
were "free of tumor". Adjuvant radiotherapy was administered to 1
(50%) patient with local recurrence (margin depth not specified)
and 3 (11%) patients without local recurrence all of whom had 20%
or less tumor necrosis (one margin less than 5  mm, one margin
unspecified). The maximum tumor diameter in non-recurring and
recurring patients averaged 11.2 cm and 15.8 cm, respectively.
Conclusion: Even with the use of adjuvant radiotherapy, several
recent large reviews have reported 20%–25% local recurrence rates
with the most important risk factor being the surgical margins of
the resection specimen. In our series, there was only a 7% local
recurrence rate which is even more remarkable when it is noted
that, of the patients without local recurrence who had exact mar-
gins recorded, nearly 80% had a surgical margin of 5mm or less.
Thus the presence of microscopically close or positive resection
margins in our series did not correlate with local recurrence. Fur-
thermore, only 4/29 (14%) patients underwent postoperative radi-
otherapy  and  no  patient  underwent  preoperative  radiotherapy
suggesting that radiation did not significantly contribute to this low
recurrence rate. While systemic chemotherapy is generally admin-
istered in an attempt to improve overall survival, our results imply
that the killing of malignant cells in the periphery of tumors with
induction chemotherapy can improve local control and postopera-
tive function by allowing for the removal of a minimum amount of
normal tissue with an acceptable rate of local recurrence.
088 Spermatic Cord Sarcoma: Outcome, Patterns of Failure 
and Management
Matthew T. Ballo, Gunar K. Zagars, Peter W. T. Pisters, Barry 
W. Feig, Shreyaskumar R. Patel, Andrew C. von Eschenbach
UT M.D. Anderson Cancer Center
Objective: To evaluate the outcome, elucidate the patterns of fail-
ure and suggest  treatment  strategies  for  sarcoma arising  in the
spermatic cord.
Methods: Between 1956  and 1998,  32 patients  were identified
through a search of our patient registry with the diagnosis of non-
metastatic spermatic cord sarcoma. A retrospective review of dis-
ease outcome, patterns  of relapse  and patient survival was per-
formed.
Results: Histologic subtypes of sarcoma were: malignant fibrous
histiocytoma (12 patients), leiomyosarcoma (6 patients), liposar-
coma (8 patients), and other subtypes (6 patients). All patients had
radical  orchidectomy  with  or  without  additional  resection  to
achieve negative margins. Margins were microscopically negative
in 29 and positive in three. Three patients received adjuvant radi-
ation to the surgical site. With a median follow-up of 9 years, 14
patients have died resulting in a 10- and 15-year actuarial overall
survival of 63% and 52%, respectively. The actuarial 10- and 15-
year local control, distant metastasis-free and disease-free survival
rates  were  72%  and 61%,  85%  and 85%,  and 60%  and 51%,
respectively. Pattern of failure analysis revealed 8 local failures, 2
regional failures within the pelvis and 6 distant failures. Of the 6
distant  failures 2 included synchronous para-aortic lymph  node
metastases resulting in an actuarial 15-year para-aortic failure rate
of 7%. Only three of the seven patients in whom disease recurred
locally were salvaged. None of the three patients treated with com-
bined surgery and radiation relapsed.
Conclusion: Spermatic  cord  sarcoma  has a  high  propensity for
local recurrence following surgery, while para-aortic nodal failures
remain uncommon. This result suggests a role for localized radio-
therapy to the pelvis. Elective surgery or irradiation of the para-
aortic lymph nodes appears unnecessary.
094 Neoadjuvent Adriamycin and Twice Daily Radiotherapy 
in Adult Soft Tissue Sarcoma
John Heiner, Minesh Mehta, Howard Bailey, Jack Fowler, 
Timothy Kinsella, Michael Lamson, F. Kristian Storm
University of Wisconsin Medical School Department of Surgery – 
Surgical Oncology, Orthopedics, Biostatistics and the Department of 
Human Oncology – Radiation Therapy, Medical Oncology
Objective: A series of limb salvage trials at UCLA employing pre-
operative continuous infusion of adriamycin (ADR), either intraar-
terially (IA) or intravenously (IV), followed by daily radiotherapy
treatments  were performed. External  beam  radiation (XRT) to
total doses of 35 Gy (3.5 Gy x 10), 28 Gy (3.5 Gy x 8), or 17.5 GyS20 CTOS  abstracts
(3.5 Gy x 5), were analyzed with the findings that both local recur-
rence and wound complications were radiation dose dependent
but independent of the route of ADR administration. ADR and
28-35 Gy XRT daily over 8–10 days resulted in effective limb sal-
vage  (96%–100%)  with  5%–10%  local  recurrence  (LR)  at  36
month median, but there were 10%–23% major wound complica-
tions requiring reoperation. We postulated that twice-daily doses
of lower fraction size XRT might achieve a similarly low incidence
of local recurrence with a further reduction in postoperative wound
complications.
Methods: The  patients  in  Group  1  (n=10)  were  treated  with
intraarterial adriamycin by continuous infusion to a total dose of
90 mg over a 3 day period. The patients in Group 2 (n=43) were
treated with the same dose intravenously. Radiation was begun 1
to 2 days after the completion of chemotherapy. The patients in
Group 1 were treated with 3.5 Gy qd X 8 days. The patients in
Group 2 were treated with 2 Gy BID X 8 days. Patients were eval-
uated for perioperative wound complications using the late effects
on normal tissues scoring system. Patients were also evaluated for
local recurrence.
Results: 53 patients with Grade IIB and Grade IIIB lesions under-
went treatment. Average follow-up was 47 months. Average great-
est tumor diameter was 8.00 cm in Group 1 and 8.82 cm in Group
2. There was 1 (10%) local recurrence in Group 1 and 1 (2.33%)
local recurrence in Group 2. There were 3 major complications
(30%) and 2 minor complications (20%) in Group 1. There were
2 (4.65%) major complications and 9 (20.93%) minor complica-
tions in Group 2. This suggested a decreased complication rate
with  twice  daily  dosing however statistical  significance  was  not
achieved (p=0.091).
Conclusion: We interpret these results to indicate that preopera-
tive IV-ADR and 28-32 Gy XRT over 8 days results in effective
limb salvage and similarly low rates of LR, but that 2.0 Gy deliv-
ered twice daily to a total dose of 32 Gy appears to lower the inci-
dence of postoperative complications.
095 What should be the Surgical Treatment of Gists? 
Research on 18 Patients with Gists
Takeo Sato1, Matthias Peiper1, Thomas Storeichert1, Annette 
Fritscher-ravens2, Wolfram-Trundo Knoefel1, Nib Soehendra2, 
Jacob R. Izbicki1
1Dept. of General Surgery, University of Hamburg, 2Dept. of 
Endoscopy, University of Hamburg
Objective: The diagnosis and treatment of gastrointestinal stro-
mal tumors (GISTs) is still a field of intensive investigation. Since
1990  we performed exact clinical examination of GISTs of the
stomach  which were treated over ten years in this  hospital,  we
report.
Methods: This is a retrospective study of 18 patients with GIST
that were treated in our hospital from 1990 to 1999. The docu-
mented  parameters  were  diagnosis  especially  endosonography,
surgical  treatment,  pathological  diagnosis,  TNM  classification,
and the prognosis.
Results: 9 males and 9 females with a mean age of 61 years (34–
83).  In  most  of  the  cases  the  symptoms  were  unspecific.  13
patients suffered from nausea, 3 patients had stomach pain, and
GI-bleeding was present in 2 patients. The diagnosis was achieved
by endoscopy and endosonography, a biopsy was taken in 2 cases.
One  of  them  showed a  PAPll  and other  a PAPlll  lesion. Liver
metastasis was found in 2 patients before the operation. 8 patients
received a total gastrectomy with splenectomy, 5 patients a distal
gastrectomy, a gastric fundectomy was performed in 2 patients and
3 patients were treated by local resection. The 2 patients showing
liver metastasis received a liver excision. The postoperative patho-
logical diagnosis revealed in all of these cases GISTs. The lymph
node metastasis was found to one patient. The average of tumor
size was 10.3cm. 5 patients were T1, and 13 patients showed T2.
10 patients were G1, 4 patients showed G2, and 4 patients were
G3. R0 was performed in 17 patients, and 1 patient was received
R1. In 2 cases metastasis was found after operation, one of them
showed peritonitic carcinomatosis. The death due to GIST was
shown with four cases and the mean survival term was 52 months
(range 4–98).
Conclusion: Our  data  suggests  that  in  absence  of  criteria  for
malignancy the resection of submucosal tumors is not indicated.
GISTs cause metastasis only in few cases while metastasis to dis-
tant lymph nodes is very rare. We perform close controls in these
patients,  in  suspicious  cases  or  if  complications  occur  we  per-
formed a resection.
097 Isolated Limb Infusion: A Novel Treatment for Locally 
Advanced Soft Tissue Sarcoma of the Extremity
Robert C.G. Martin, Karen Brown, Mary S. Brady
Memorial Sloan-Kettering Cancer Center Department of Surgery
Objective: Isolated limb infusion (ILI) is a technique of delivering
regional chemotherapy to the extremity in patients with advanced
melanoma  or  soft  tissue  sarcoma  (STS).  ILI  is  performed  by
administering high doses of chemotherapy into a normothermic,
hypoxic, and low flow circuit via angiographically placed catheters
after a tourniquet is placed around the proximal extremity. Unlike
the standard approach of isolated limb perfusion (ILP), no surgical
incision is required. In addition, the procedure is less time con-
suming, lends itself to repeat treatments and is associated, in our
initial experience, with a shortened hospital stay and less morbidity
than conventional ILP.
Methods: We report our experience with a 60 year old man who
presented with a rapidly growing, high grade STS of the calf. The
tumor was unresectable other than by amputation due to encase-
ment of the nerves and vasculature. The patient was treated with
neoadjuvant chemotherapy (high dose adriamycin and ifosfamide)
and progressed on this regime (see figure). The patient underwent
ILI with melphalan and dactinomycin and had significant tumor
shrinkage resulting  in  restoration of  his  dorsalis  pedis  pulse. A
second ILI was performed 10 weeks later resulting in a decrease in
the dimensions of his tumor by MRI from 12.2cm x 7.8cm prior to
the first infusion to 5.5cm x 7.3cm 8 weeks after his second (see
figure).  The  patient  remains  without  systemic  disease,  and  23
weeks after his initial ILI has experienced no significant morbidity
from his regional therapy.
Results: Figure: Tumor volume by MRI in relation to treatment.
Conclusion: ILI  using melphalan and dactinomycin may be an
effective means of regional control in patients with unresectable
STS with less morbidity than ILP.
107 Predictive Factors for Wound Complications following 
Free and Pedicled Soft Tissue Flaps for Limb 
Reconstruction After Excision of Soft Tissue Tumours
A T Abudu1, R S Bell1, A M Griffin1, B O O’Sullivan2, 
C N Catton2, A M Davis1, J S Wunder1
1University Musculoskeletal Oncology Unit, Mount Sinai Hospital, 
University of Toronto, 2Department of Radiation Oncology, Princess 
Margaret Hospital
Objective: The  literature  on the  outcome  of  patients  with  soft
tissue sarcoma who require soft tissue reconstruction with free or
pedicled flaps is scanty. We investigated the risk factors for wound
complications in patients with soft tissue sarcoma of the extremity
who required reconstructive soft tissue flaps. We also comparedCTOS  abstracts S21
the  local  oncologic  control  in  patients  requiring  reconstructive
flaps with those in whom primary wound closure was possible.
Methods: Prospectively collected database records and the clini-
cal data of all the patients who underwent excision of soft tissue
sarcoma of the extremity and reconstruction with a free or pedicled
soft  tissue  flaps  at  our  centre  were  retrospectively  reviewed.
Wound complication was defined as a complication at the site of
tumour excision necessitating a return trip to the operating room
or prolonged wound packing. Chi-square test was used for analysis
of nominal data.
Results: 113 consecutive patients with soft tissue sarcoma who
had limb preserving surgery with soft tissue reconstructive flaps
were  studied.  The  minimum  follow-up  was  24  months.  The
mean age was 55 years (16–95). The sarcoma was located in the
lower extremity in 83 and upper extremity 30 patients. Adjuvant
radiotherapy  was  administered  pre-operatively  in  64  patients,
post-operatively in 31, brachytherapy in 4 and no radiotherapy in
14  patients.  Significant  wound complications  developed in 37
patients (33%). The most common complications were wound
infections or partial necrosis occurring in 16% (18/113) and 13%
(15/113)  respectively.  Complete  flap  necrosis  requiring  flap
removal  occurred  in  6  patients  (5%).  Three  patients  (2.3%)
required amputation as a result of the complications. The statis-
tically significant risk factors for development of wound compli-
cations include location of tumour in the lower limb compared to
upper limb (relative risk 2.3, p=0.02) and use of pre-operative
radiotherapy compared to no or post-operative radiotherapy (rel-
ative risk 2.05, p=0.02). There was no difference in rates of com-
plications in patients with free or pedicled flaps, tumors < or >
5cm, distal or proximal location of tumour. The rates of negative
excision  margins  (80%)  and wound  complications  in  patients
who required reconstructive flaps were not different from that for
the other patients treated at our center who did not require recon-
structive flaps.
Conclusion: The  use  of  soft  tissue  reconstructive  flaps  did not
reduce the risk of positive excision margins or the rates of wound
complications. Pre-operative radiotherapy and tumors located in
the lower limb are the main risk factors for wound complications
after the use of reconstructive flaps. The risk of amputation sec-
ondary to flap complication or failure is low.
108 The Indications and Prognostic Significance of 
Amputation for Soft Tissue Sarcoma of the Extremity
A T Abudu1, N Driver1, J S Wunder1, A M Griffin1, D Pearce1, 
B O O’Sullivan2, C N Catton2, R S Bell1, A M Davis1
1University Musculoskeletal Oncology Unit, Mount Sinai Hospital, 
University of Toronto, 2Department of Radiation Oncology, Princess 
Margaret Hospital
Objective: Limb preserving surgery has become the treatment of
choice for patients with soft tissue sarcoma but a small group of
patients remain unsuitable for limb preserving surgery and require
amputation for the local control of their sarcoma. The prognostic
significance of the need for amputation to achieve local control in
patients with soft tissue sarcoma is unclear. We studied patients
with soft tissue sarcoma of the extremity to determine the reasons
for amputation, and the outcome following amputation compared
to those patients treated with limb preserving surgery.
Methods: The  clinical  charts,  prospectively  collected  database
records,  radiological  investigations  and  pathological  records  of
patients with soft tissue sarcoma treated at our centre were studied.
The patients who had primary amputation, and those who had
amputation after complications of limb sparing surgery, were stud-
ied to identify the reasons for amputations.
Results: 812  consecutive  patients  were  studied.  774  patients
(95.3%)  had  limb-sparing  surgery  and  38  (4.7%)  had  primary
amputations. Patients with primary amputations were statistically
more likely to have metastases at presentation (16% versus 7%),
high grade tumours (82% versus 49%), larger tumours (median
diameter 11cm versus 7cm) and were older (61 versus 53 years).
Multivariate analysis using time dependent Cox model in patients
with localised disease at diagnosis revealed that the requirement for
primary amputation was a poor prognostic factor for overall and
disease free survival independent of tumour grade, tumour size and
patients’ age. The reasons for primary amputation were: 1) tumour
excision would result in inadequate function (13 of 38 patients); 2)
large extracompartmental tumours with composite tissue involve-
ment  including  major  vessels,  nerves  and  bone  (eight  of  38
patients); 3) local recurrence in previously irradiated field (seven of
38  patients);  4)  involvement  of  major  neurovascular  structures
(five of 38 patients); 5) prior unplanned resection with extensive
tissue contamination (three of 38 patients); 6) multifocal disease
(one of 38 patients) and 7) concurrent peripheral vascular disease
(one of 38 patients).
Conclusion: Patients  who  require  primary  amputations  are  a
select group with unfavourable tumour characteristics and have a
poor prognosis. The are likely to present with metastases and those
with localised disease at the time of treatment develop metastases
much earlier compared to patients in whom limb preserving sur-
gery is possible. The requirement for a primary amputation is an
independent poor prognostic factor in patients with localised dis-
ease at diagnosis.
110 Low Dose Radiotherapy and Staged Surgical Resection 
For Diffuse Pigmented Villonodular Synovitis of the Knee 
Preserves Normal Knee Function with Minimal Risk of 
Recurrence
Marc Rankin1, Felasfa M. Wodajo2, James Wittig2, Kari 
Mansour2, Martin M. Malawer2
1Division of Orthopedics, Howard University Hospital, 2Washington 
Cancer Institute, Washington Hospital Center
Objective: Pigmented villonodular synovitis (PVNS) of the knee
is a benign, proliferative synovial disorder characterized by knee
pain and recurrent effusions. Recent karyotype chromosomal anal-
ysis suggest that it is a true neoplasm and not an inflammatory
process. There is a localized and a diffuse form of the disorder with
the localized or nodular version amenable to limited, even arthro-
scopic resection. The treatment strategy for diffuse PVNS, how-
ever, has to address the tendency of the lesion to recur quickly
following an incomplete resection. Our objective is to evaluate the
results of a uniformly applied, multimodal treatment protocol for
diffuse PVNS consisting of surgery and radiation.
Methods: During the period of 1990 to the present, 19 patients
underwent surgical resection for PVNS of the knee by the same
surgical team. Of these, 8 patients underwent staged procedures
for diffuse PVNS consisting of an anterior arthrotomy and syn-
ovectomy followed 3 months  later  by posterior  arthrotomy and
synovectomy. After wound healing was complete, patients under-
went external beam radiotherapy, most commonly consisting of
3000 cGy in 15 fractions. Patients were followed postoperatively at
3–6  month intervals  by physical  exam and magnetic  resonance
imaging (MRI). Five patients who completed treatment between
1995 and 1998 form the basis for this report.
Results: The study group consists of three females and two males
with an average age of 25 years (range 14–43 years) at the time of
surgery. The average follow-up interval was 30 months (range 5–
57 months). Three patients presented with recurrent disease after
either an anterior arthrotomy or arthroscopy by another surgeon,
one patient presented after two previous arthroscopies. Average
post-operative knee extension at the most recent examination was
+3 deg (range 0–15 deg) and average flexion was 127 deg (range
115–135 deg). Four of five patients had no complaints of pain nor
reported  any  restriction  of  desired  activities;  the  youngest  two
patients  (17  and  25  years  old)  were  athletically  active.  Four
patients had no knee effusion at their last visit. One patient whoS22 CTOS  abstracts
was  47  years  old  had  a  small  effusion  and  occasional  activity
related pain and was noted radiographically to have developed a
moderate amount of degenerative osteoarthrosis of the knee in the
five year interval since treatment. There were no recurrences.
Conclusion: As evidenced by the finding that 4 out of 5 of the
study patients presented to us with recurrent disease, anterior syn-
ovectomy or arthroscopy alone is probably inadequate treatment
for this disorder. The extent of tumor in diffuse PVNS is easily
underestimated and requires thorough anterior and posterior knee
exploration  as  tumor  often extends  extraarticularly, particularly
posteriorly  along  the  semimembranous  tendon  complex.  Most
published reports on knee PVNS are generally retrospective analy-
ses, often incorporating various treatments and extents of disease.
We have demonstrated that a protocol consisting of staged anterior
and posterior synovectomy with adjuvant low dose external beam
radiation for diffuse PVNS of the knee can provide excellent func-
tional results with a low risk of recurrence.
121 Intraperitoneal Chemotherapy (IPC) After Complete 
Resection of Peritoneal Sarcomatosis (PS): Results of a 
Monocentric Randomized Study
Bonvalot Sylvie, Calvacanti Andrea, Elias Dominique, Terrier 
Philippe, Vanel Daniel, Lepechoux Cecile, Le Cesne Axel
Institut Gustave Roussy
Objective: In  order to  decrease locoregional relapse  after com-
plete resection of PS, the role of IPC was prospectively evaluated.
Methods: Patients (pts) with complete resection of PS were rand-
omized between adjunction of IPC or not. IPC consisted of Dox-
orubicin,  0.1  mg/kg  and  Cisplatin,  15  mg/m2  every  day  for  5
consecutive days.
Results: Thirty-eight consecutive pts  have been enrolled in the
study, 19 in each group (IPC-, IPC+) with a M/F sex ratio of 14/
24. Median age was 58 (39 to 72) and 48 yrs (31 to 71) in IPC-
and IPC+ group respectively. Ratio of retroperitoneal (RPS) and
visceral  (VS)  sarcomas were  9/10  and 6/13  in  IPC- and IPC+
group respectively. Histoprognostic grade and median number of
organs resected during surgery were similar in both groups. Sugar-
baker score of sarcomatosis were 13 (3, 27) and 13,7 (2, 20) in
IPC- and IPC+ respectively. There was no toxic deaths and mor-
bidity was similar in both groups (4 pts in each group). Median
time of hospitalization was 22 days (range 11 to 39) for IPC- and
24 days (range 15 to 42) for IPC+. The median follow-up is 36
months. The median local relapse-free survival and overall survival
were identical in both groups, 12.5 and 18 months respectively
with no difference between RPS and VS.
Conclusion: Addition of IPC did not modify outcome of pts after
complete resection of RPS and VS. OS and DFS of this study are
similar to those observed in phase II studies combining IPC with
hyperthermia. An optimal surgery of PS remains the only prognos-
tic factor for survival.
128 Is there a Role for Isolated Limb Perfusion in 
Unresectable Extremity Sarcomas?
Barry W. Feig
The University of Texas M.D. Anderson Cancer Center
Objective: A number of recent studies from Europe have reported
on the efficacy of isolated limb perfusion (ILP) in patients with
unresectable extremity sarcomas. Unfortunately, these results have
been difficult to reproduce in studies performed in the U.S. As sys-
temically  delivered  doxorubicin has  shown  the  most  activity  in
patients with soft tissue sarcomas, we were interested in evaluating
the use of doxorubicin delivered via ILP. We therefore undertook
a Phase I trial of ILP with doxorubicin using the dosing previously
reported from a phase I dose escalation trial from Italy. (Rossi et
al. Cancer 73:2140-2146, 1999)
Methods: Seven patients have been entered in this Phase I trial; 6
patients have been perfused, the seventh patient was unable to be
perfused secondary to inadequate venous access. There were 3
males and 3 females with a median age of 33 (range 19–75). The
initial 3 patients were treated at a dose of 1.4 mg/kg for the lower
extremity (LE) and 0.7 mg/kg for the upper extremity (UE). The
dose was lowered 20% in the second 3 patients to 1.0mg/kg and
0.5mg/kg for the LE and UE respectively, secondary to toxicity
seen in the first 3 patients. The perfusion was performed using a
bubble  oxygenator,  roller  pump  in  the  standard,  previously
described manner. The perfusion with doxorubicin was performed
for 60  minutes at normothermic  temperatures (37oC). Patients
were then evaluated for response to treatment using MRI scan at 6
weeks post perfusion. At that time patients underwent marginal
excisions of the tumors.
Results: In the 6 patients thus far perfused, there have been no
responses seen. Three patients had evidence of disease progression
at the time of their 6 week MRI evaluation. There was one grade
3, and one grade 2 neurologic toxicity. Two patients have under-
gone  amputation  secondary  to  progression  of  disease.  Two
patients have had evidence of significant myonecrosis based on ele-
vated CPK levels post-operatively (27,000 and 31,000) with signif-
icant post-operative limb dysfunction requiring extending physical
therapy treatments.
Conclusion: Thus far, there have been no responses observed in
this  study  population. Additionally,  there  have  been  significant
toxicities observed, as described above in the results section. The
lack of responses seen to ILP with doxorubicin in this study, as well
as the low response rates seen in other perfusion studies performed
in the United States, makes it unlikely that there is a role for ILP
in patients with unresectable extremity sarcomas.
132 Phase I Trial of Preoperative Doxorubicin-Based 
Concurrent Chemoradiation and Surgical Resection For 
Localized, Resectable Extremity and Trunk Soft Tissue 
Sarcomas (STS)
Peter W.T. Pisters, Shreyaskumar R. Patel, Valerae O. Lewis, 
Kristin L. Weber, Patrick P. Lin, Rex Marco, Alan W. Yasko, 
Kelly K. Hunt, Barry W. Feig, Jonathan C. Trent II
The University of Texas M. D. Anderson Cancer Center
Objective: Doxorubicin is active against soft tissue sarcoma and is
a potent radiosensitizer. However, no prior studies have examined
continuous infusion doxorubicin combined with concurrent radia-
tion for patients with STS. This phase I trial is designed to define
the toxicities of concurrent doxorubicin and external beam radio-
therapy (EBRT) followed by surgical resection in order to establish
the maximum tolerated dose (MTD) of doxorubicin when com-
bined with standard preoperative EBRT.
Methods: Patients with localized, resectable grade II or III pri-
mary or recurrent STS of the trunk and extremity are eligible.
EBRT (2 Gy/fraction, 25 fractions) is provided with continuous
infusion doxorubicin (starting dose 10 mg/m2/week, Monday to
Thursday, x 5 weeks). Doxorubicin dose escalation is determined
by the continuous reassessment method (CRM). 23 patients have
been  treated.  The  dose  escalation  scheme  (and  number  of
patients treated) for successive cohorts of patients according to
the CRM method has been: 12.5 mg/m2 per week (1 patient),
15.0  mg/m2  per  week (3  patients), 17.5  mg/m2 per  week (19
patients).CTOS  abstracts S23
Results: The median tumor size was 9.8 cm (range, 1.8–22 cm).
Histologies included unclassified sarcoma (8 patients), malignant
fibrous histiocytoma (7 patients), liposarcoma (4 patients), and 3
patients with other STS. With 23 of 30 planned patients treated,
the MTD by CRM appears to be 17.5 mg/m2 per week; 7 patients
remain to be treated for complete  assessment.  Grade III local
cutaneous  toxicity  (confluent  moist  desquamation)  has  been
observed in 5 patients treated at the 17.5 mg/m2 per week dose
level. Grade III neutropenia was observed in 2 patients treated at
the 17.5 mg/m2 dose level; no patients have experienced febrile
neutropenia.
Conclusion: Concurrent continuous infusion doxorubicin-based
chemoradiotherapy appears feasible and safe. The MTD of doxo-
rubicin appears to be 17.5 mg/m2 per week when doxorubicin is
administered by continuous infusion over 4 days/week for 5 suc-
cessive weeks with 50 Gy of preoperative EBRT.